News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more.
The test is US Food and Drug Administration approved for detecting recent hyperglycemia and hyperglycemic excursions in patients with diabetes.
The firm aims to bring to market a point-of-care technology that would significantly reduce the expense associated with highly sensitive diabetes testing.
The partners will make a test for monitoring Tysabri available to clinicians and clinical trial partners through ResearchDx's reference laboratory.
The partners will conduct an exploratory study to determine how the results of Exagen's lupus test impacts primary care physician practice referral patterns.
The firm aims to integrate protein biomarker measurements, data from patient wearables, and imaging to improve treatment and management of multiple sclerosis.
